These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8795269)

  • 1. Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. II. Synthesis and antitumor activity of N5-substituted glutamine analogs.
    Itoh F; Yoshioka Y; Yukishige K; Yoshida S; Wajima M; Ootsu K; Akimoto H
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1498-509. PubMed ID: 8795269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. III. Synthesis and biological properties of N(omega)-masked ornithine analogs.
    Itoh F; Yoshioka Y; Yukishige K; Yoshida S; Ootsu K; Akimoto H
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1270-80. PubMed ID: 10993224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and X-ray crystal structure of a potent dual inhibitor of thymidylate synthase and dihydrofolate reductase as an antitumor agent.
    Gangjee A; Yu J; McGuire JJ; Cody V; Galitsky N; Kisliuk RL; Queener SF
    J Med Chem; 2000 Oct; 43(21):3837-51. PubMed ID: 11052789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
    Gangjee A; Devraj R; McGuire JJ; Kisliuk RL
    J Med Chem; 1995 Sep; 38(19):3798-805. PubMed ID: 7562910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. I: Synthesis and biological properties of pyrrolo[2,3-d]pyrimidine antifolates containing tetrazole congener of glutamic acid.
    Itoh F; Yukishige K; Wajima M; Ootsu K; Akimoto H
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):230-5. PubMed ID: 7728929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Arylthio-substituted 2-amino-4-oxo-6-methylpyrrolo[2,3-d]pyrimidine antifolates as thymidylate synthase inhibitors and antitumor agents.
    Gangjee A; Devraj R; McGuire JJ; Kisliuk RL
    J Med Chem; 1995 Oct; 38(22):4495-502. PubMed ID: 7473577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of N-[4-[1-ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid as an antifolate.
    Gangjee A; Zeng Y; McGuire JJ; Kisliuk RL
    J Med Chem; 2002 Apr; 45(9):1942-8. PubMed ID: 11960504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of a classical 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine as antifolates.
    Gangjee A; Yang J; McGuire JJ; Kisliuk RL
    Bioorg Med Chem; 2006 Dec; 14(24):8590-8. PubMed ID: 16990006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical and nonclassical furo[2,3-d]pyrimidines as novel antifolates: synthesis and biological activities.
    Gangjee A; Devraj R; McGuire JJ; Kisliuk RL; Queener SF; Barrows LR
    J Med Chem; 1994 Apr; 37(8):1169-76. PubMed ID: 8164259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activities of novel 6-5 fused ring heterocycle antifolates: N-[4-[omega-(2-amino-4-substituted-6,7-dihydrocyclopenta [d]pyrimidin-5-yl)alkyl]benzoyl]-L-glutamic acids.
    Kotake Y; Iijima A; Yoshimatsu K; Tamai N; Ozawa Y; Koyanagi N; Kitoh K; Nomura H
    J Med Chem; 1994 May; 37(11):1616-24. PubMed ID: 8201595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.
    Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL
    J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological activities of classical N-[4-[2-(2-amino-4-ethylpyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and its 6-methyl derivative as potential dual inhibitors of thymidylate synthase and dihydrofolate reductase and as potential antitumor agents.
    Gangjee A; Yu J; Kisliuk RL; Haile WH; Sobrero G; McGuire JJ
    J Med Chem; 2003 Feb; 46(4):591-600. PubMed ID: 12570380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antifolate, and antitumor activities of classical and nonclassical 2-amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines.
    Gangjee A; Vidwans A; Elzein E; McGuire JJ; Queener SF; Kisliuk RL
    J Med Chem; 2001 Jun; 44(12):1993-2003. PubMed ID: 11384244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzoyl ring halogenated classical 2-amino-6-methyl-3,4-dihydro-4-oxo-5-substituted thiobenzoyl-7H-pyrrolo[2,3-d]pyrimidine antifolates as inhibitors of thymidylate synthase and as antitumor agents.
    Gangjee A; Jain HD; McGuire JJ; Kisliuk RL
    J Med Chem; 2004 Dec; 47(27):6730-9. PubMed ID: 15615522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1).
    Gangjee A; Jain HD; Phan J; Lin X; Song X; McGuire JJ; Kisliuk RL
    J Med Chem; 2006 Feb; 49(3):1055-65. PubMed ID: 16451071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 6-5 fused ring heterocycle antifolates with potent antitumor activity: bridge modifications and heterocyclic benzoyl isosters of 2,4-diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine antifolate.
    Kotake Y; Okauchi T; Iijima A; Yoshimatsu K; Nomura H
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):829-41. PubMed ID: 7553969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of C9-methyl substitution and C8-C9 conformational restriction on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
    Gangjee A; Zeng Y; McGuire JJ; Kisliuk RL
    J Med Chem; 2000 Aug; 43(16):3125-33. PubMed ID: 10956221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.
    Gangjee A; Jain HD; Phan J; Guo X; Queener SF; Kisliuk RL
    Bioorg Med Chem; 2010 Jan; 18(2):953-61. PubMed ID: 20056546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.